Products

CT CoPilot
Cortechs.ai
Radiology & Imaging AI
CT CoPilot by ZEPMED (now part of Cortechs.ai) is an FDA-cleared AI tool for automated analysis, segmentation, and reformatting of head CT scans to improve radiology interpretation and diagnostic accuracy.
RSI-MRI+
Cortechs.ai
Oncology AI
RSI-MRI+ is an FDA-cleared AI-powered imaging software by HealthLytix (now CorTechs Labs) that uses Restriction Spectrum Imaging (RSI) to enhance the detection and diagnosis of prostate cancer through improved visualization and quantification of restricted water in MRI scans.
NeuroQuant
Cortechs.ai
Neurology AI
NeuroQuant by CorTechs Labs is an FDA-cleared, AI-powered software for automated brain MRI segmentation and volumetric analysis, aiding in the diagnosis and monitoring of neurodegenerative diseases, brain trauma, and tumors.

See all 3 products →

About Cortechs.ai

Cortechs.ai is a healthcare AI company that specializes in AI-powered medical imaging analysis software. Their mission is to enhance patient care by providing physicians with AI solutions for improved detection, diagnosis, and treatment of neurological and oncological diseases. The company merges state-of-the-art medical imaging with machine learning and clinical data to develop advanced tools that aim to improve patient outcomes and optimize clinical workflows.

Cortechs.ai’s product suite includes NeuroQuant®, a leading software for brain segmentation and volumetric analysis, which is crucial for assessing neurodegenerative diseases like Alzheimer’s, multiple sclerosis, and traumatic brain injury. They also offer NeuroQuant MS for visualizing and tracking lesions, NeuroQuant Brain Tumor for pre- and post-operative 3D volumetric analysis of brain tumors, and NeuroQuant PET and CT for automated tracer activity quantification and CT alignment, respectively. Additionally, Cortechs.ai provides OnQ™ Prostate for advanced prostate MRI analysis, aiding in prostate cancer detection and characterization. These solutions are designed to integrate seamlessly into radiology workflows, providing quantitative insights that support faster interpretation and more confident clinical decision-making.

Focus Areas

AI-powered medical imaging neuroimaging quantitative imaging neurological conditions oncological conditions Alzheimer's disease epilepsy multiple sclerosis brain tumors prostate cancer radiology workflow optimization

Business Intelligence

TechnologyAI-powered imaging analysis software, cloud-native (Microsoft Azure)

What Physicians Need to Know

AI-Powered Neuroimaging
Cortechs.ai specializes in AI-powered neuroimaging solutions, particularly with their flagship product, NeuroQuant®. This software provides automated segmentation and quantitative volumetric analysis of brain structures, aiding in the detection, diagnosis, and monitoring of various neurological conditions.
Neurological Conditions Expertise
Their solutions cater to a broad spectrum of neurological disorders, including Alzheimer's disease, epilepsy, multiple sclerosis, brain tumors, traumatic brain injury, and microvascular ischemic disease.
Oncological Conditions Expertise
Cortechs.ai also extends its AI solutions to oncological conditions, specifically focusing on brain tumors (gliomas, metastases, and meningiomas) and prostate cancer.
Quantitative Imaging Pioneer
Cortechs.ai is recognized as a pioneer in quantitative medical imaging, having released NeuroQuant® in 2002, which was a groundbreaking milestone in medical imaging.
Radiology Workflow Optimization
Their AI-powered software is designed to optimize radiology workflows by providing objective insights, reducing variability in interpretations, and streamlining the analysis of medical images.
Alzheimer's Disease Management
NeuroQuant® plays a crucial role in Alzheimer's disease care by delivering accurate, AI-driven volumetric analysis of brain structures over time, assisting in diagnosis, monitoring disease progression, and supporting pre-treatment eligibility screening for disease-modifying therapies.
Multiple Sclerosis (MS) Lesion Tracking
NeuroQuant® MS specifically enhances radiology workflows for MS by automatically identifying, quantifying, and tracking lesions, providing objective volumetric data, and visualizing changes in lesion dynamics over time.
Brain Tumor Analysis
NeuroQuant® Brain Tumor offers automated segmentation and volumetric reporting for various brain tumors, including gliomas, brain metastases, and meningiomas, supporting pre- and post-operative analysis and longitudinal tracking of tumor changes.
Prostate Cancer Imaging
OnQ™ Prostate optimizes prostate MRI for advanced clinical insights in prostate cancer detection, monitoring, and treatment. It utilizes Restriction Spectrum Imaging (RSI) to improve the conspicuity and characterization of suspicious lesions.
CT and PET Capabilities
Cortechs.ai also offers NeuroQuant® CT for automated CT software for fast, accurate diagnosis and NeuroQuant® PET for rapid, automated subregional tracer quantification.
Physician Tip

Cortechs.ai's solutions provide objective, quantitative data to support clinical impressions, reduce inter-reader variability, and enhance diagnostic confidence. The longitudinal tracking capabilities are invaluable for monitoring disease progression and treatment response in neurological and oncological conditions. Their tools are designed to integrate seamlessly into existing radiology workflows, improving efficiency and productivity. Understanding the specific Category III CPT codes (e.g., 0865T, 0866T for NeuroQuant® and 0648T, 0649T for OnQ Prostate™) is crucial for reimbursement.

Cortechs.ai's solutions are cloud-based and designed for seamless integration into Picture Archiving and Communication Systems (PACS). They also have partnerships with major healthcare technology providers like Viz.ai, GE Healthcare, Siemens Healthineers, and Philips Healthcare, and their solutions are available through platforms like CARPL.ai, expanding access and interoperability within healthcare networks.

Products by Cortechs.ai

3 products in the directory

CT CoPilot
Cortechs.ai
Radiology & Imaging AI
CT CoPilot by ZEPMED (now part of Cortechs.ai) is an FDA-cleared AI tool for automated analysis, segmentation, and reformatting of head CT scans to improve radiology interpretation and diagnostic accuracy.
RSI-MRI+
Cortechs.ai
Oncology AI
RSI-MRI+ is an FDA-cleared AI-powered imaging software by HealthLytix (now CorTechs Labs) that uses Restriction Spectrum Imaging (RSI) to enhance the detection and diagnosis of prostate cancer through improved visualization and quantification of restricted water in MRI scans.
NeuroQuant
Cortechs.ai
Neurology AI
NeuroQuant by CorTechs Labs is an FDA-cleared, AI-powered software for automated brain MRI segmentation and volumetric analysis, aiding in the diagnosis and monitoring of neurodegenerative diseases, brain trauma, and tumors.

What the Web Says

Cortechs.ai (formerly CorTechs Labs) is a company specializing in AI-driven medical imaging solutions for diagnosing neurological and prostate health conditions. The company focuses on providing quantitative imaging insights to support clinical and research decision-making. While direct product reviews for Cortechs.ai's specific offerings like NeuroQuant are not readily available on major review platforms like G2, Capterra, or Glassdoor, general sentiment around the company as an employer appears mixed, with some positive aspects regarding work-life balance and benefits, but also concerns about management and career advancement in some instances.

Overall: Mixed

Strengths

  • Driven by purpose and collaboration in the workplace
  • Valued employee contributions and encouragement for professional and personal growth
  • Ownership of projects and tangible impact across business functions for employees
  • Strong leadership and supportive team culture
  • Comprehensive benefits package including 401(k), health insurance, and paid time off
  • Good work-life balance

Limitations

  • Limited opportunities for job security and advancement in some roles
  • Mixed reviews on management, with some negative experiences reported
  • Some employees reported not feeling appreciated for their work
  • Lack of consistent support and proper procedures in some departments
  • Issues with HR and timely hiring processes reported by some recruiters

Based on reviews from: Indeed.com, Cortechs.ai Careers, Owler Company Profile

Last updated: 2026-10-19

Videos

News, demos, and interviews about Cortechs.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cortechs.ai →

View all on YouTube

Press & Coverage

PR Newswire
Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions
Cortechs.ai announced an oversubscribed funding round to accelerate innovation in AI-powered neuroimaging and oncology solutions, driven by growing demand for their cutting-edge technology. This capital infusion will support further advancements in their offerings.
2024-11
Cortechs.ai
Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions
Cortechs.ai announced a strategic partnership with CARPL.ai to expand global access to their AI-powered neuroimaging solutions, aiming to revolutionize disease screening and early detection. The collaboration will make their medical device software more widely available for quantifying and tracking neurodegenerative diseases and detecting cancer.
2026-10
PR Newswire
Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows
Cortechs.ai is collaborating with Microsoft to integrate its AI-powered imaging solutions, including NeuroQuant® and OnQ™ Prostate, directly into Microsoft's PowerScribe One and broader ecosystem. This aims to deliver quantitative imaging results within radiology reporting tools and enhance diagnostic confidence.
2026-06
AuntMinnie
Cortechs.ai wins FDA clearance for NeuroQuant PET
Cortechs.ai received U.S. Food and Drug Administration 510(k) clearance for NeuroQuant PET, an automated quantification platform for amyloid PET imaging in Alzheimer's disease and other neurological conditions. The software generates structured reports of standardized uptake value ratios (SUVRs) and Centiloid measurements.
2026-08
Cortechs.ai
Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth
Cortechs.ai announced the expansion of its European CE Marking under the EU Medical Device Regulation (EU MDR) for its latest imaging products, including NeuroQuant® Version 5 and NeuroQuant® Brain Tumor. This milestone expands access to their innovations and supports global growth.
2026-08
Cortechs.ai news
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration
Viz.ai, a leader in AI-powered disease detection, announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite. This partnership expands Viz.ai's offerings into neurodegenerative disease.
2026-07
Cortechs.ai news
Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East
Cortechs.ai announced a strategic partnership with ARJ Medical to advance AI-driven neuroimaging and quantitative imaging solutions in the Middle East. This collaboration aims to expand access to their technology in the region.
2026-05
Cortechs.ai news
Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies
Cortechs.ai announced a strategic partnership with Siemens Healthineers to expand global access to its NeuroQuant® technologies. This collaboration aims to make their AI-powered neuroimaging solutions more widely available.
2026-03

Frequently Asked Questions

Cortechs.ai provides quantitative neuroimaging solutions, such as NeuroQuant and LesionQuant, that automatically segment and measure brain structures and lesions to aid in the diagnosis and monitoring of conditions like Alzheimer's disease, multiple sclerosis, and epilepsy. For oncology, their solutions assist in quantifying and tracking brain tumors and prostate cancer, optimizing radiology workflows by providing objective data.
Cortechs.ai's products are designed to seamlessly integrate with existing PACS and EMR systems, providing automated quantitative analysis that can be accessed directly within the radiologist's workflow. This integration aims to reduce manual measurement time, standardize reporting, and provide objective data to support clinical decision-making, thereby optimizing efficiency and potentially improving diagnostic accuracy.
Cortechs.ai's products are FDA 510(k) cleared and CE marked, demonstrating their adherence to stringent regulatory standards for medical devices. They also prioritize data security and patient privacy, implementing robust measures to ensure compliance with healthcare regulations like HIPAA, safeguarding sensitive patient information throughout the imaging and analysis process.
Cortechs.ai offers various pricing models, which can include per-study fees, subscription-based licenses, or enterprise-wide agreements, tailored to the specific needs and volume of the healthcare institution. They provide comprehensive support, including technical assistance, clinical training, and ongoing customer service to ensure optimal utilization and integration of their solutions within clinical practice.
Cortechs.ai collaborates with leading academic institutions and technology partners to advance their AI imaging solutions and expand their clinical applications. As a pioneer in quantitative neuroimaging, the company has established a strong market presence and continues to invest in research and development, indicating a commitment to long-term stability and innovation in the healthcare AI landscape.
For Alzheimer's disease, NeuroQuant quantifies atrophy in brain regions associated with the condition, aiding in early detection and monitoring disease progression. For epilepsy, it helps identify subtle structural abnormalities that may be epileptogenic. In multiple sclerosis, LesionQuant automatically detects and measures lesion burden and changes over time, assisting in disease management and treatment response assessment.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.